• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

bijun.zeng@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology

Dr Bijun Zeng

Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology

20 Scholarly works
1 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Development of a circulating tumour cell culture model from head and neck squamous cell carcinoma
    DOI: 10.1002/VIW.20250085
  • 2025

    Conference Proceedings

    210. Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens
    DOI: 10.1093/dote/doaf061.314
  • 2025

    Journal article

    Correction to: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers (Oncogene, (2025), 44, 13, (893-908), 10.1038/s41388-024-03259-y)
    DOI: 10.1038/s41388-025-03319-x
  • 2025

    Journal article

    CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
    DOI: 10.1038/s41388-024-03259-y
  • 2023

    Journal article

    Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines
    DOI: 10.3390/cells12162094
  • 2023

    Journal article

    Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models
    DOI: 10.3389/fimmu.2023.1127896
  • 2022

    Research Grant

    Liposomal Antigen-Specific Immunotherapy of Recent-Onset Type 1 Diabetes
Bijun Zeng

RECENT SCHOLARLY WORKS

  • 2022

    Journal article

    Biophysical properties of hydrogels for mimicking tumor extracellular matrix
    DOI: 10.1016/j.bioadv.2022.212782
  • 2021

    Journal article

    Targeting replication stress using CHK1 inhibitor promotes innate and NKT cell immune responses and tumour regression
    DOI: 10.3390/cancers13153733
  • 2020

    Journal article

    Tumor-Microenvironment-on-a-Chip for Evaluating Nanoparticle-Loaded Macrophages for Drug Delivery
    DOI: 10.1021/acsbiomaterials.0c00650
  • 2020

    Journal article

    Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells
    DOI: 10.1002/cti2.1157

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224